2026 ITP Annual Patients’ Convention – ITP Support Association
ITP Support Association shared a post on LinkedIn:
“A Huge Thank You to Our Platinum Sponsor: argenx
As we head toward the 2026 ITP Annual Patients’ Convention, we wanted to take a moment to highlight the incredible support of our Platinum Sponsor, argenx.
Partnerships like this are vital for the ITP community. They allow us to host world-class events at venues like the Royal College of Pathologists and ensure that patients and families have access to the very latest in medical research and care.
Argenx is at the forefront of developing innovative therapies for autoimmune G-mediated diseases. Their commitment to the ITP space helps move the needle from the tough journey of diagnosis toward better long-term management and improved quality of life.
What to look forward to at the convention:
Cutting-Edge Research: Learn about new developments in the field that are changing how we look at platelet counts.
Expert Discussions: Hear from specialists who are working alongside partners like argenx to find better solutions for patients.
Community Connection: A chance to meet the teams who are dedicated to supporting the ITP Support Association’s mission.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 12:37Rutuja Mahadik: Anemia is More Than Just Feeling Tired
-
Jun 1, 2026, 12:36Ankur Jindal: Large-Vessel Inflammation and Immune Dysregulation in Wiskott–Aldrich Syndrome
-
Jun 1, 2026, 12:35Shadi Almassri: Conditions That Can Cause False High or False Low HbA1c Results
-
Jun 1, 2026, 12:22Ed Davidson: Clot Removing Technology That Can Change the Game
-
Jun 1, 2026, 12:17Tagreed Alkaltham: Building Blood Systems for Both Efficiency and Resilience
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?